Clinical Trial Update: Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing three neoadjuvant chemotherapy regimens (CEFci, CEF, and EC) for primary breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Tao OUYANG | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED